Investor Notice: The Rosen Law Firm Announces Investigation of Securities Claims Against China Shenghuo Pharmaceutical Holdings, Inc.


NEW YORK, Aug. 21, 2008 (GLOBE NEWSWIRE) -- Attorney Advertising. The Rosen Law Firm announces that it is investigating potential civil securities claims against China Shenghuo Pharmaceutical Holdings, Inc. ("CSP" or the "Company") (AMEX:KUN) concerning allegations that CSP issued materially false and misleading financial statements in violation of the federal securities laws.

On August 20, 2008, the Company announced that its previously issued financial statements for the fiscal periods ended June 30, September 30, and December 30, 2007 and fiscal quarter ended March 31, 2008, should no longer be relied upon and would be restated due to certain accounting errors, internal control issues and related matters. This adverse announcement shocked the market causing the Company's stock to fall approximately 25%.

As a result of these adverse disclosures, the Rosen Law Firm is investigating potential claims against CSP for violation of the of the federal securities laws and is preparing a class action complaint.

If you purchased CSP's stock during July 23, 2007 through August 20, 2008, and would like further information concerning your legal rights, please contact Laurence Rosen, Esq. or Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at lrosen@rosenlegal.com or pkim@rosenlegal.com.

You may access the website at http://www.rosenlegal.com to contact the Rosen Law Firm for additional information.

The Rosen Law Firm concentrates its practice on representing investors in securities class actions and protecting shareholder rights.

Attorney advertising. Prior results do not guarantee a similar outcome.



            

Tags


Contact Data